Journal of Aerosol Medicine and Pulmonary Drug Delivery

Scope & Guideline

Exploring new frontiers in aerosol therapy.

Introduction

Explore the comprehensive scope of Journal of Aerosol Medicine and Pulmonary Drug Delivery through our detailed guidelines, including its aims and scope. Stay updated with trending and emerging topics, and delve into declining areas to understand shifts in academic interest. Our guidelines also showcase highly cited topics, featuring influential research making a significant impact. Additionally, discover the latest published papers and those with high citation counts, offering a snapshot of current scholarly conversations. Use these guidelines to explore Journal of Aerosol Medicine and Pulmonary Drug Delivery in depth and align your research initiatives with current academic trends.
LanguageEnglish
ISSN1941-2711
PublisherMARY ANN LIEBERT, INC
Support Open AccessNo
CountryUnited States
TypeJournal
Convergefrom 2008 to 2024
AbbreviationJ AEROSOL MED PULM D / J. Aerosol Med. Pulm. Drug Deliv.
Frequency6 issues/year
Time To First Decision-
Time To Acceptance-
Acceptance Rate-
Home Page-
Address140 HUGUENOT STREET, 3RD FL, NEW ROCHELLE, NY 10801

Aims and Scopes

The Journal of Aerosol Medicine and Pulmonary Drug Delivery focuses on advancing the science and application of aerosol-based therapies, particularly in the domain of respiratory medicine. The journal encompasses a multidisciplinary approach that includes pharmacology, engineering, and clinical studies to enhance drug delivery systems and their efficacy in treating respiratory conditions.
  1. Aerosol Drug Delivery Systems:
    Research in this area includes the development and optimization of various aerosol drug delivery devices, such as metered-dose inhalers (MDIs), nebulizers, and dry powder inhalers (DPIs). Studies often focus on how device characteristics influence drug delivery efficiency and patient outcomes.
  2. Pharmacokinetics and Pharmacodynamics of Inhaled Medications:
    This includes investigations into the absorption, distribution, metabolism, and excretion of inhaled drugs. Understanding the pharmacokinetic profiles of medications delivered via aerosols is crucial for optimizing dosing regimens and therapeutic efficacy.
  3. Innovative Formulation Development:
    Research on novel formulations, including liposomal, nanoparticle, and polymer-based systems, aims to enhance the stability, solubility, and delivery of active pharmaceutical ingredients (APIs) through inhalation.
  4. Clinical Outcomes and Patient-Centric Studies:
    The journal emphasizes studies that evaluate the clinical effectiveness of aerosol therapies in real-world settings, focusing on patient adherence, usability of inhalation devices, and overall treatment outcomes.
  5. In Vitro and In Vivo Models:
    A significant portion of research employs advanced in vitro and in vivo models to simulate respiratory conditions and assess aerosol deposition, drug efficacy, and safety profiles.
The Journal of Aerosol Medicine and Pulmonary Drug Delivery has witnessed a dynamic evolution in its thematic focus, reflecting emerging trends in aerosol therapy and respiratory medicine. Recent publications indicate a strong inclination towards innovative technologies and novel therapeutic approaches.
  1. Nanoparticle and Nanotechnology Applications:
    Increasing interest in the use of nanoparticles for drug delivery, particularly for targeting lung diseases such as tuberculosis and cancer, highlights a shift toward more sophisticated and effective inhalation therapies.
  2. Personalized Medicine Approaches:
    Research into personalized inhalation therapies that consider individual patient characteristics and preferences is gaining traction, indicating a move towards more tailored therapeutic strategies.
  3. Impact of E-Cigarettes and Vaping on Respiratory Health:
    With the rise in vaping, studies examining the effects of e-cigarette aerosols on respiratory function and health outcomes are becoming more prevalent, reflecting public health concerns.
  4. Advanced In Vitro Models for Drug Testing:
    The development of sophisticated in vitro systems that mimic human respiratory conditions for drug testing is emerging as a critical area of research, enhancing the predictive value of preclinical studies.
  5. Sustainability in Aerosol Delivery Devices:
    There is a growing focus on developing environmentally sustainable inhaler technologies, particularly in response to regulatory pressures and public demand for greener pharmaceutical practices.

Declining or Waning

While the journal continues to explore a broad range of topics related to aerosol medicine, certain themes appear to be declining in prominence over recent years. These waning scopes may reflect shifts in research focus or advancements in technology that render previous areas less critical.
  1. Traditional Nebulization Techniques:
    Research on conventional nebulizer systems appears to be declining as newer technologies, such as vibrating mesh nebulizers and soft mist inhalers, gain popularity for their efficiency and patient convenience.
  2. Non-Inhalation Drug Delivery Methods:
    There is a noticeable decrease in studies focusing on non-inhalation methods of drug delivery within the context of aerosol medicine, as the field shifts towards optimizing inhaled therapies specifically.
  3. Basic Aerosol Science without Clinical Application:
    While foundational aerosol science remains relevant, there seems to be a waning interest in purely theoretical studies that do not directly contribute to clinical applications or improvements in patient care.
  4. Pharmacokinetics of Non-Respiratory Drugs:
    Research focused on the pharmacokinetics of drugs not intended for respiratory diseases has diminished, as the journal's emphasis shifts towards inhaled therapies specifically tailored for respiratory conditions.

Similar Journals

PULMONARY PHARMACOLOGY & THERAPEUTICS

Unveiling breakthroughs in pulmonary therapeutics.
Publisher: ACADEMIC PRESS LTD- ELSEVIER SCIENCE LTDISSN: 1094-5539Frequency: 6 issues/year

Welcome to Pulmonary Pharmacology & Therapeutics, a leading journal dedicated to the dissemination of innovative research and insights in the fields of pulmonary medicine and pharmacology. Published by Academic Press Ltd - Elsevier Science Ltd, this journal has made significant contributions to the academic community since its inception in 1997, with an ongoing commitment to relevant advancements projected through to 2024. With reputable Q2 rankings across vital categories including Biochemistry (medical), Medicine (miscellaneous), Pharmacology (medical), and Pulmonary and Respiratory Medicine, Pulmonary Pharmacology & Therapeutics is ranked in the top tier of its field, reflecting its impact on the discipline as evidenced by its Scopus rankings. Researchers, healthcare professionals, and students alike can access a wealth of high-quality articles that address the complexity of pulmonary diseases and therapeutic strategies, supporting research and clinical practice alike. Join the vibrant community contributing to this essential field and explore the latest findings that can drive change in patient care and therapeutic effectiveness.

Journal of Pharmaceutical Health Care and Sciences

Fostering collaboration for transformative healthcare solutions.
Publisher: BMCISSN: 2055-0294Frequency: 1 issue/year

The Journal of Pharmaceutical Health Care and Sciences is a premier open access journal published by BMC that aims to advance the field of pharmaceutical sciences by providing high-quality research and comprehensive reviews across various domains including pharmacology, nursing, and healthcare. With an impact factor reflecting its relevance and rigor, the journal has established itself as a significant platform for disseminating knowledge since its inception in 2015. The journal is indexed in Scopus, currently holding a position in the Q3 quartile for medical pharmacology and Q2 quartile for nursing pharmacology, indicating its growing influence and reach in the scientific community. Based in the United Kingdom with a commitment to open access, the Journal of Pharmaceutical Health Care and Sciences ensures that all researchers, professionals, and students have free access to vital research that fosters innovation and improves healthcare outcomes worldwide. With a focus on collaborative and multidisciplinary approaches, the journal invites contributions that align with its objectives of enhancing health care delivery and pharmaceutical practices.

European Journal of Pharmacology

Fostering interdisciplinary collaboration in the realm of pharmacology.
Publisher: ELSEVIERISSN: 0014-2999Frequency: 24 issues/year

The European Journal of Pharmacology, a prestigious publication by Elsevier, serves as a vital resource in the field of pharmacology, offering rich insights into drug development and therapeutic applications. Since its inception in 1967, this journal has evolved to encompass groundbreaking research, including pharmacokinetics, toxicology, and innovative pharmacological methodologies, making it an essential platform for researchers and professionals alike. With an impressive impact factor that places it in the Q1 category of pharmacological journals and a Scopus ranking of #49 out of 313, the journal is recognized in the 84th percentile within its category, solidifying its significance in the academic community. Although the journal is not open access, it continues to attract contributions from leading scientists worldwide, ensuring that cutting-edge findings are disseminated effectively. The European Journal of Pharmacology not only highlights advancements in drug discovery and clinical applications but also promotes interdisciplinary collaboration, ultimately contributing to the progress of healthcare globally.

PHARMACEUTICAL RESEARCH

Exploring the frontiers of pharmaceutical research and application.
Publisher: SPRINGER/PLENUM PUBLISHERSISSN: 0724-8741Frequency: 12 issues/year

PHARMACEUTICAL RESEARCH, published by SPRINGER/PLENUM PUBLISHERS, is a leading journal in the ever-evolving field of pharmaceutical sciences. With an ISSN of 0724-8741 and an E-ISSN of 1573-904X, this journal has established itself as a critical hub for disseminating innovative research from 1984 to 2024. The journal holds impressive rankings in prominent categories, including Q2 in Biotechnology and Q2 in Pharmaceutical Science, reflecting its robust impact on the global scientific community. The journal aims to provide researchers, professionals, and students with high-quality articles that contribute significantly to the advancement of drug development and medicinal applications. Although it does not currently offer Open Access options, its rigorous peer-review process ensures that only the highest caliber research is published, making it a valuable resource for those seeking to stay at the forefront of pharmaceutical innovation.

JOURNAL OF PHARMACY AND PHARMACOLOGY

Driving excellence in pharmacy and pharmacological research.
Publisher: OXFORD UNIV PRESSISSN: 0022-3573Frequency: 12 issues/year

Journal of Pharmacy and Pharmacology, published by Oxford University Press, is a prestigious academic journal dedicated to the advancement of knowledge in the fields of pharmaceutical sciences and pharmacology. With a strong heritage dating back to 1949, this journal maintains a robust influence, as evidenced by its ranking in the second quartile (Q2) across both Pharmaceutical Science and Pharmacology categories for 2023. The journal is accessible without an open access option, ensuring traditional academic engagement and providing valuable insights for researchers and professionals. It boasts an impressive Scopus ranking, with a percentile positioning of 72nd in Pharmaceutical Science and 67th in Pharmacology. Aimed at fostering innovative research and facilitating the exchange of cutting-edge scientific knowledge, the Journal of Pharmacy and Pharmacology serves as an essential resource for scientists, students, and healthcare professionals committed to enhancing therapeutic outcomes and advancing pharmaceutical innovations.

Journal of Reports in Pharmaceutical Sciences

Empowering Researchers with Cutting-Edge Findings.
Publisher: WOLTERS KLUWER MEDKNOW PUBLICATIONSISSN: 2322-1232Frequency: 2 issues/year

Journal of Reports in Pharmaceutical Sciences is a pivotal publication in the realm of pharmaceutical research, disseminating innovative findings that cater to the evolving landscape of pharmacology, toxicology, and biomedical engineering. Published by Wolters Kluwer Medknow Publications, the journal serves as a bridge for scholars and practitioners aiming to enhance their understanding of drug development, therapeutic advances, and biopharmaceutical technologies. With an ISSN of 2322-1232 and E-ISSN 2322-5106, it has established its relevance from 2012 to 2022, occupying notable quartile rankings, including Q3 in Pharmacology, Toxicology, and Pharmaceutics. Despite being categorized in Q4 in some areas, the journal's commitment to quality research ensures it remains a respected platform for disseminating significant insights. Researchers, professionals, and students alike will find this journal an indispensable resource for staying updated on critical advancements in pharmaceutical sciences, making it a go-to source for impactful studies that shape industry practices and academic inquiries.

JOURNAL OF PHARMACOLOGY AND EXPERIMENTAL THERAPEUTICS

Shaping the Future of Therapeutics Through Rigorous Inquiry
Publisher: AMER SOC PHARMACOLOGY EXPERIMENTAL THERAPEUTICSISSN: 0022-3565Frequency: 12 issues/year

The JOURNAL OF PHARMACOLOGY AND EXPERIMENTAL THERAPEUTICS, published by the American Society for Pharmacology and Experimental Therapeutics, stands as a pivotal platform in the fields of pharmacology and molecular medicine. With an impressive convergence of knowledge from 1945 to 2024, this esteemed journal is recognized for its rigorous peer-reviewed research, contributing significantly to our understanding of drug action and therapeutic interventions. It holds a commendable position in the Q2 quartile in both Molecular Medicine and Pharmacology, emphasizing its relevance and impact within the contemporary scientific landscape, as evidenced by its Scopus ranking that places it amongst the leading journals in its category. Aimed at researchers, professionals, and students, the journal not only fosters a deeper insight into toxicology, pharmacodynamics, and therapeutic strategies but also encourages innovation through its comprehensive access to groundbreaking experimental methodologies. The journal continues to foster discourse and disseminate research that shapes the future of pharmacological science.

Pharmaceutical Sciences

Advancing pharmaceutical knowledge for a healthier future.
Publisher: TABRIZ UNIV MEDICAL SCIENCES, FAC PHARMACYISSN: 1735-403XFrequency: 4 issues/year

Pharmaceutical Sciences, an esteemed journal published by Tabriz University of Medical Sciences, Faculty of Pharmacy, serves as a crucial platform for the dissemination of pioneering research in the fields of pharmaceutical science, pharmacology, and toxicology. With an impact factor reflective of its substantial contribution to the scientific community, this open access journal has been accessible since 2012, ensuring that researchers, professionals, and students worldwide can engage with its rich content. Located in Iran, it has continually evolved, covering research from 2009 to 2024, and boasts impressive rankings in multiple Scopus categories, including Q3 in Pharmaceutical Science and Q2 in Pharmacology, Toxicology and Pharmaceutics. By bridging gaps between scientific inquiry and practical applications, Pharmaceutical Sciences is dedicated to advancing pharmaceutical knowledge and promoting innovative practices that address significant health challenges.

Drug Delivery and Translational Research

Bridging Innovation and Application in Drug Delivery.
Publisher: SPRINGER HEIDELBERGISSN: 2190-393XFrequency: 12 issues/year

Drug Delivery and Translational Research (ISSN: 2190-393X | E-ISSN: 2190-3948), published by Springer Heidelberg, stands at the forefront of the Pharmaceutical Sciences discipline, boasting a prestigious impact factor as evidenced by its Q1 category ranking in 2023. This esteemed journal is dedicated to the vital intersection of drug delivery systems and translational research, aiming to bridge the gap between laboratory findings and clinical applications. It features groundbreaking studies that enhance our understanding of drug pharmacokinetics, formulations, and patient-centered research, making it indispensable for researchers, professionals, and students striving to innovate and excel in the field. While the journal operates under a subscription model, its commitment to disseminating high-quality research is reflected in its Scopus rank, placing it in the top 6% of its category (Rank #11/183, 94th percentile). Since its inception in 2011, it has garnered significant attention, promoting advances in pharmacology, toxicology, and pharmaceutics, and continues to be a platform for vital discourse and discovery.

Drug Design Development and Therapy

Elevating Drug Discovery with High-Impact Research
Publisher: DOVE MEDICAL PRESS LTDISSN: 1177-8881Frequency: 1 issue/year

Drug Design Development and Therapy is a premier open-access journal published by DOVE MEDICAL PRESS LTD, dedicated to advancing the fields of drug discovery, pharmaceutical science, and pharmacology. With an impressive Q1 ranking in its categories as of 2023, this journal is recognized for its significant contributions to the understanding of drug design and therapeutic innovations, making it an invaluable resource for researchers, professionals, and students alike. Established in 2007 and committed to open-access since 2008, the journal provides an inclusive platform for disseminating high-quality research from around the globe. With a robust impact factor and remarkable Scopus rankings, including a 24th place in Pharmaceutical Science and a 48th place in Pharmacology, it reflects a strong percentile performance, ensuring that published articles reach and impact a wide audience. By fostering the exchange of cutting-edge information on drug development and delivery systems, Drug Design Development and Therapy continues to play a crucial role in the ongoing battle against disease, promoting innovative approaches to therapeutic solutions and enhancing patient care.